Earlier in October, Pfizer Inc (NYSE: PFE ... budget by $1.1 billion over the next three years while it aims to get FDA ...
November 13, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback